Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

copd

Genetic study reveals new associations with lung disease and smoking behaviour

September 25, 2015 Medical Communications, Research and Development COPD, lung cancer, smkoing

New research published in The Lancet Respiratory Medicine and presented at this year’s European Respiratory Society (ERS) Congress in Amsterdam …
News
BI building

Boehringer and BioMed X crowdsource top scientists to fight COPD

September 23, 2015 Research and Development Boehringer Ingelheim, COPD

Boehringer Ingelheim and BioMed X have used a crowdsourcing strategy to establish a global research team to collaborate on the …
News
HIV infected cell

ViiV in late-stage HIV trial success

September 23, 2015 Research and Development HIV, Triumeq, ViiV, virology

Switching patients to Triumeq, a once-daily combination treatment for HIV, is as effective as remaining on antiretroviral therapy in certain …
News

Pharma ‘is getting better at drug R&D’

September 23, 2015 Research and Development R&D, drug development, market access, productivity

An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …
News
scottish_highlands

Vision for hi-tech manufacturing in the Scottish highlands

September 22, 2015 Manufacturing and Production, Research and Development GSK, Scotland, manufacturing

Scottish life and chemical science firms claim Scotland is an ideal European base for UK and global manufacturers. A new …
News
Esbriet

Roche to present new Esbriet data at ERS Congress 2015

September 21, 2015 Research and Development, Sales and Marketing Esbriet, European Respiratory Congress, Roche, idiopathic pulmonary fibrosis, pirfenidone

Roche has announced it will present new data analyses of Esbriet in idiopathic pulmonary fibrosis (IPF) at the European Respiratory …
News
Jardiance

More positive CV data for Boehringer and Lilly’s Jardiance

September 21, 2015 Research and Development, Sales and Marketing Boehringer Ingelheim, EASD, Eli Lilly, cardiovascular risk, empagliflozin, jardiance, mortality risk, type 2 diabetes

Jardiance, an anti-diabetes drug produced by Boehringer Ingelheim and Eli Lilly, reduces the risk of death in people with type …
News

Biocair opens new site in Belgium

September 21, 2015 Research and Development, Sales and Marketing Biocair

Biocair is pleased to announce the opening of its new premises in Belgium. The new state of the art facility …
News
Press release

FDA grants Opdivo breakthrough status for kidney cancer

September 18, 2015 Research and Development, Sales and Marketing BMS, Breakthrough Therapy Designation, Bristol-Myers Squibb, FDA, Kidney cancer, immuno-oncology, immunotherapy, nivolumab, opdivo, renal cell carcinoma

The FDA has given Bristol-Myers Squibb’s immuno-oncology drug Opdivo Breakthrough Therapy Designation as a kidney cancer treatment. The FDA’s decision …
News
BIS

UK second in global innovation index

September 18, 2015 Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo

The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …
News
AstraZeneca_drug_discovery

AstraZeneca and US Government collaborate to develop new antibiotics

September 17, 2015 Research and Development AstraZeneca, Azactam, BARDA, Department of Health and Human Services, HHHS, avibactam, aztreonam

AstraZeneca has entered into a public-private partnership with the US Department of Health and Human Services to develop drugs to …
News
Amgen

Amgen joins M&A rush with deals for Dezima and Xencor

September 16, 2015 Research and Development, Sales and Marketing Amgen, Cancer, Denzime, Xencor, cardiovascular disease, high cholesterol, inflammation

Amgen has struck deals that could potentially be worth $3.25 billion, to purchase the Dutch firm Dezima and kick-off a …
News
diabetes_injection

Sanofi’s LixiLan meets target in Phase III diabetes trial

September 16, 2015 Research and Development Lantus, LixiLan, Lixisenatide, Lxyumia, Sanofi, diabetes, insulin glargine, metformin, type 2 diabetes

Sanofi’s Phase III clinical trial of its Lixilan treatment has achieved its primary endpoint in patients with type 2 diabetes, …
News
clinical trial

The biggest side-effect of making medicine

September 16, 2015 Research and Development evergreening, intellectual property, patent

International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people …
Feature

R&D firms team up to tackle antibiotic resistance

September 16, 2015 Research and Development AMR, Antibiotics, Jim O'Neill, O'Neill review, antimicrobial resistance, drug development

Two companies at the centre of the UK’s R&D efforts to tackle the growing threat of resistance to antibiotics are expanding …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026